Terlipressin Åõ¿© ÈÄ ¹ß»ýÇÑ Àú³ªÆ®·ýÇ÷Áõ¿¡ ÀÇÇÑ °£Áú¹ßÀÛ 1¿¹
A Case of Hyponatraemic Seizure Following Terlipressin Therapy fora Variceal Hemorrhage in a Patient with Liver Cirrhosis

´ëÇѳ»°úÇÐȸÁö 2014³â 87±Ç 3È£ p.323 ~ p.327

±èÁøÈñ(Kim Jin-Hee) - ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
±èÀÚ°æ(Kim Ja-Kyung) - ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
¹®¼Ò¿µ(Mun So-Yeong) - ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
ÃÖûÁ¶(Choi Chung-Jo) - ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
¹ÚÇѹÎ(Park Han-Min) - ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
Á¤¿ë¼³(Jeong Yong-Seol) - ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
°­Áر¸(Kang Jun-Goo) - ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç

Abstract

TerlipressinÀº vasopressin À¯»ç¾àÁ¦ÀÌÁö¸¸ ±×¿¡ ºñÇØ ºÎÀÛ¿ëÀÌ Àû°Ô ¹ß»ýÇÏ¿© ¾ÈÀüÇÏ°Ô »ç¿ëµÇ´Â Ç÷°ü¼öÃàÁ¦·Î °£°æº¯¿¡¼­ÀÇ Á¤¸Æ·ù ÃâÇ÷À̳ª °£½ÅÁõÈıº Ä¡·á¿¡ ÀÏÂ÷ÀûÀ¸·Î »ç¿ëµÇ°í ÀÖ´Ù. TerlipressinÀº vasopressin°ú ´Ù¸£°Ô V2 ¼ö¿ëüº¸´Ù V1 ¼ö¿ëü¿¡ ÁÖ·Î ÀÛ¿ëÇϱ⠶§¹®¿¡ V2 ¼ö¿ëü¿Í °ü·ÃµÈ Ç×ÀÌ´¢ ÀÛ¿ëÀ̳ª ³ªÆ®·ý´¢ ¹è¼³Ç×ÁøÀÌ °ÅÀÇ ÀϾÁö ¾Ê´Â´Ù°í ¾Ë·ÁÁ³´Ù. ±×·¯³ª ½ÇÁ¦ ÀÓ»ó¿¡¼­ terlipressin¿¡ ÀÇÇØ SIAD°¡ ¹ß»ýÇÏ°í ±×·Î ÀÎÇØ Àú³ªÆ®·ýÇ÷ÁõÀÌ »ý±ä ¿¹°¡ ´Ù¾çÇÏ°Ô º¸°íµÇ°í ÀÖ´Ù. º» Áõ·Ê¿¡¼­´Â terlipressin Åõ¿©·Î ÀÎÇØ SIAD°¡ ¹ß»ýÇÑ °ÍÀ¸·Î »ý°¢µÇ¸ç ±× °á°ú ÁßÁõÀÇ Àú³ªÆ®·ýÇ÷Áõ°ú ±×·Î ÀÎÇÑ °æ·Ã¹ßÀÛÀ» ÀÏÀ¸Ä×À¸³ª terlipressinÀ» Áß´ÜÇÏ°í ¼öºÐ ¼·Ã븦 Á¦ÇÑÇÏ´Â µîÀÇ SIAD¿¡ ÁØÇÑ Ä¡·á ÈÄ¿¡ Áõ»óÀÌ ¸ðµÎ È£ÀüµÈ ¿¹¸¦ °æÇèÇÏ¿´±â¿¡ À̸¦ ¹®Çå°íÂû°ú ÇÔ²² º¸°íÇÏ´Â ¹ÙÀÌ´Ù.
Terlipressin has splanchnic vasoconstrictive effects, and is generally used for the management of gastroesophageal variceal bleeding secondary to liver cirrhosis. Terlipressin is a synthetic arginine vasopressin (AVP) analog containing a nonapeptide sequence. Terlipressin has increased selectivity for the V1 receptor, compared with AVP; hence, it is considered to be a safe vasoconstrictor. However, side effects such as hyponatremia and seizure, although very rare, have been reported. Hyponatremia related to terlipressin may be caused by the syndrome of inappropriate antidiuresis (SIAD), which is a disorder of sodium and water balance characterized by hypotonic hyponatremia without elevation of the antidiuretic hormone level. Here, we report a case of hyponatremic seizure induced by an infusion of terlipressin in a 52-year-old female who had isolated gastric variceal bleeding secondary to alcoholic liver cirrhosis.

Å°¿öµå

Terlipressin, Àú³ªÆ®·ýÇ÷Áõ, ¹ßÀÛ
Terlipressin, Hyponatremia, Seizure
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå